🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, Phase II, randomized, double-blind, placebo-controll...
Status
Completed
Location
Pinnacle Research Group; Llc, Central
Start Date
2016-09-09
Trial ID
NCT02833350
Treatments Being Tested
A study to evaluate the long-term safety and efficacy of GDC-0853 in partic...
Status
Completed
Location
Arizona Arthritis & Rheumatology Associates, P.C.
Start Date
2016-11-30
Trial ID
NCT02983227
Treatments Being Tested
The purpose of this study is to investigate the safety, tolerability, and p...
Status
Completed
Location
West Coast Clinical Trials
Start Date
2017-01-24
Trial ID
NCT03188783
This open-label, Phase I study will evaluate the safety, tolerability, and ...
Status
Completed
Location
Stanford Cancer Center
Start Date
2013-12-16
Trial ID
NCT01991184
Treatments Being Tested
This Phase II, multicenter, open-label extension (OLE) study will evaluate ...
Status
Terminated
Location
Valerius Medical Group
Start Date
2018-01-09
Trial ID
NCT03407482
Treatments Being Tested
The purpose of this study is to evaluate the PK of GDC-0853 following chang...
Status
Completed
Location
Quotient Clinical Ltd, Clinical Research Unit
Start Date
2017-04-18
Trial ID
NCT03290703
Treatments Being Tested
This study is a Phase I, single center, randomized (Parts 1 and 2 only), op...
Status
Completed
Location
Quotient Clinical Ltd, Clinical Research Unit
Start Date
2015-09-03
Trial ID
NCT02699710
Treatments Being Tested
This is a Phase II, multicenter, open-label extension (OLE) study to evalua...
Status
Terminated
Location
Clinical Research Center of Alabama, LLC
Start Date
2018-09-27
Trial ID
NCT03693625
Treatments Being Tested
This is a study to evaluate the safety and efficacy of GDC-0853 in combinat...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-01-19
Trial ID
NCT02908100
The purpose of this study is to evaluate the efficacy, safety and pharmacok...
Status
Completed
Location
Clinical Research Center of Alabama, LLC
Start Date
2017-05-26
Trial ID
NCT03137069